期刊文献+

Avastin联合黄斑格栅样光凝治疗DME的视力预后的多因素分析

Multi-factor analysis of the effects on visual acuity prognosis of intravitreal Avastin and macular grid photocoagulation for diabetic macular edema
下载PDF
导出
摘要 目的:探讨影响玻璃体腔注射Avastin联合黄斑格栅样光凝治疗糖尿病黄斑水肿(diabetic macular edema,DME)后患者视力的相关因素。方法:回顾性分析Avastin联合黄斑格栅样光凝治疗糖尿病黄斑水肿患者41例41眼。运用SPSS14.0分析患者性别、年龄、病程、治疗前最佳矫正视力(BCVA)、治疗前黄斑中心凹视网膜厚度(CMT)、DME类型、治疗后CMT变化、黄斑中心凹下有无大片硬性渗出与治疗后BCVA之间的相关性。结果:在治疗后1mo时,BCVA与病程、治疗前BCVA、黄斑水肿减轻程度及黄斑中心凹下是否有大片硬性渗出相关(P<0.05)。结论:选择术前视力较好、病程短、黄斑中心凹下无大片硬性渗出的患者经联合治疗后可获得较好的视力。 AlM:To investigate the related factors of effects on best-corrected visual acuity (BCVA) after intravitreal Avastin combined with macular grid photocoagulation(MGP) for diabetic macular edema(DME). METHODS:A retrospective review of a consecutive series of 41 DME patients(41 eyes) who received intravitreal Avastin combined with MGP. Gender, disease course, the changes of central macular thickness (CMT), type of DEM, changes of postoperative CMT, massive subfoveal hard exudates and visual acuity 1 month after treatment were recorded. Multi-factor regression analysis of BCVA after the combined treatment was performed with SPSS statistics software. P0.05 was considered statistically significant. RESULTS: The postoperative BCVA was related to the preoperative BCVA, disease course, the changes of CMT and massive subfoveal hard exudates (P0.05). CONCLUSlON: The better preoperative BCVA is, the better postoperative BCVA would be. Early treatment for the patients with DME would get better postoperative BCVA. Postoperative BCVA is relatively improved in patients with obvious regression of macular edema. Patients with massive submacular hard exudates could hardly be improved in postoperative BCVA.
出处 《国际眼科杂志》 CAS 2012年第5期935-937,共3页 International Eye Science
基金 深圳市科技计划项目(No.201103371)~~
关键词 AVASTIN 黄斑格栅样光凝 糖尿病黄斑水肿 多因素分析 Avastin macular grid photocoagulation diabetic macular edema multi-factor analysis
  • 相关文献

参考文献17

  • 1Pelzek C,Lim JI.Diabetic macular edema:review and update.Ophthalmol Clin North Am2002(4);15:555-563.
  • 2Aiello LM.Perspectives on diabetic retinopathy.Am J Ophthalmol2003;136(1):122-135.
  • 3Early Treatment Diabetic Retinopathy Study Research Group.Photocoagulation for diabeticmacular edema.Early Treatment Diabetic Retinopathy Study report number I.Arch Ophthalmol1985;103(12):1796-1806.
  • 4Bandello F,Lanzetta P,Menchini U.When and how to do a grid laser for diabetic macular edema.Doc Ophthalmol1999;97(3-4):415-419.
  • 5Lee CM,Olk RJ.Modified laser grid photocoagulation for diffuse macular edema.Long term visual results.Ophthalmology1991;98(10):1594-1602.
  • 6Haritoglou C,Kook D,Neubauer A,et al.Intravitreal bevacizumab(Avastin)therapy for persistent diffuse diabetic macular edema.Retina2006;26(9):999-1005.
  • 7Arevalo JF,Fromow-Guerra J,Quiroz-Mercado H,et al.Primary intravitreal bevacizumab(Avastin)of diabetic macular edema.Ophthalmology2007;114(4):743-750.
  • 8余晓锐,王学珍.玻璃体腔注射Avastin治疗眼底病400例临床疗效总结[J].国际眼科杂志,2010,10(10):1913-1915. 被引量:14
  • 9Ornek K,Ornek N.Intravitreal bevacizumab treatment for refractory diabetic macular edema.J Ocul Pharmacol Ther2008;24(4):403-407.
  • 10Soheilian M,Ramezani A,Bijanzadeh B,et al.Intravitreal bevacizumab(Avastin)injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.Retina2007;27(9):1187-1195.

二级参考文献9

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部